The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Rivastigmine in the treatment of parkinsonian psychosis and cognitive impairment: Preliminary findings from an open trial
Abstract
This open study assessed the ability of rivastigmine to treat the neuropsychiatric complications of advanced Parkinson's disease. In a group of 12 patients, hallucinations, sleep disturbance, and carer distress were all improved and cognitive performance significantly enhanced by the drug. © 2001 Movement Disorder Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia
Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994) · Neurology · doi:10.1212/wnl.44.12.2308 · Cited by 7,568
Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale
Fahn, S. (1987) · Medical Entomology and Zoology · Cited by 2,163
Recent Developments in Parkinson's Disease
Hurtig, H. I. (1987) · Neurology · doi:10.1212/wnl.37.5.893 · Cited by 1,920
McKeith, I., Del Ser, T., Spano, P., Emre, M., Wesnes, K., Anand, R., Cicin-Sain, A., Ferrara, R., & Spiegel, R. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03399-7 · Cited by 1,182
Self-citationHallucinations in Parkinson's disease: Prevalence, phenomenology and risk factors
Fenelon, G. (2000) · Brain · doi:10.1093/brain/123.4.733 · Cited by 1,037
Low-Dose Clozapine for the Treatment of Drug-Induced Psychosis in Parkinson's Disease
(1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401003 · Cited by 615
Hallucinations, REM sleep, and Parkinson’s disease: A medical hypothesis
Arnulf, I., Bonnet, A.-M., Damier, P., Bejjani, B.-P., Seilhean, D., Derenne, J.-P., & Agid, Y. (2000) · Neurology · doi:10.1212/wnl.55.2.281 · Cited by 442
Jellinger, K. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.4.540 · Cited by 373
Aarsland, D., Larsen, J. P., Cummings, J. L., & Laake, K. (1999) · Archives of Neurology · doi:10.1001/archneur.56.5.595 · Cited by 348
Levodopa-induced psychosis: a kindling phenomenon
(1978) · American Journal of Psychiatry · doi:10.1176/ajp.135.6.669 · Cited by 326
Visual Hallucinations Associated With Parkinson Disease
Sanchez-Ramos, J. R., Ortoll, R., & Paulson, G. W. (1996) · Archives of Neurology · doi:10.1001/archneur.1996.00550120077019 · Cited by 324
Neuropsychiatric aspects of Alzheimer's disease: The cholinergic hypothesis revisited
Cummings, J. L., & Kaufer, D. (1996) · Neurology · doi:10.1212/wnl.47.4.876 · Cited by 251
Nausieda, P. A., Weiner, W. J., Kaplan, L. R., Weber, S., & Klawans, H. L. (1982) · Clinical Neuropharmacology · doi:10.1097/00002826-198205020-00003 · Cited by 245
Donepezil for Treatment of Dementia With Lewy Bodies: A Case Series of Nine Patients
Shea, C., MacKnight, C., & Rockwood, K. (1998) · International Psychogeriatrics · doi:10.1017/s1041610298005341 · Cited by 229
Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease
Friedman, J. H., & Factor, S. A. (2000) · Movement Disorders · doi:10.1002/1531-8257(200003)15:2<201::aid-mds1001>3.0.co;2-d · Cited by 214
Comella, C. L., Tanner, C. M., & Ristanovic, R. K. (1993) · Annals of Neurology · doi:10.1002/ana.410340514 · Cited by 211
Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson's disease
Pappert, E. J., Goetz, C. G., Niederman, F. G., Raman, R., & Leurgans, S. (1999) · Movement Disorders · doi:10.1002/1531-8257(199901)14:1<117::aid-mds1019>3.0.co;2-0 · Cited by 181
Neuropsychiatric features of corticobasal degeneration
Litvan, I., Cummings, J. L., & Mega, M. (1998) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.65.5.717 · Cited by 179
Cholinergic‐dependent cognitive deficits in Parkinson's disease
Dubois, B., Danzé, F., Pillon, B., Cusimano, G., Lhermitte, F., & Agid, Y. (1987) · Annals of Neurology · doi:10.1002/ana.410220108 · Cited by 178
Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease
Wolters, E. C., Jansen, E. N. H., Tuynman-Qua, H. G., & Bergmans, P. L. M. (1996) · Neurology · doi:10.1212/wnl.47.4.1085 · Cited by 173
Cholinesterase inhibition in Parkinson's disease.
Hutchinson, M., & Fazzini, E. P. (1996) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.61.3.324-a · Cited by 150
Rivastigmine in the treatment of dementia with Lewy bodies: preliminary findings from an open trial
McKeith, I. G., Grace, J., Walker, Z., Byrne, E. J., Wilkinson, D. G., Stevens, T., & Perry, E. K. (2000) · International Journal of Geriatric Psychiatry · Cited by 150
Self-citationOlanzapine in dementia with Lewy bodies: a clinical study
Walker, Z., Grace, J., Overshott, R., Satarasinghe, S., Swan, A., Katona, C., & McKeith, I. G. (1999) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(199906)14:6<459::aid-gps957>3.0.co;2-r · Cited by 130
Self-citationPharmacology of hallucinations induced by long-term drug therapy
Goetz, C. G., Tanner, C. M., & Klawans, H. L. (1982) · American Journal of Psychiatry · doi:10.1176/ajp.139.4.494 · Cited by 128
Basic mechanisms of sleep generation.
Steriade, M. (1992) · PubMed · Cited by 123
Lewy bodies and response to tacrine in Alzheimer's disease
Levy, R., Eagger, S. A., Griffiths, M., Perry, E., Honavar, M., Dean, A. F., & Lantos, P. L. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90966-0 · Cited by 120
Neuropsychiatric Assessment of Patients With Hyperkinetic and Hypokinetic Movement Disorders
Litvan, I., Paulsen, J. S., Mega, M. S., & Cummings, J. L. (1998) · Archives of Neurology · doi:10.1001/archneur.55.10.1313 · Cited by 120
Psychotic Symptoms in Parkinson's Disease Patients with Dementia
Naimark, D. M. J., Jackson, E., Rockwell, E., & Jeste, D. V. (1996) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1996.tb00918.x · Cited by 97
Olanzapine in the treatment of hallucinosis in idiopathic parkinson's disease: a cautionary note
Graham, J., Sussman, J. D., Ford, K. S., & SAGAR, H. J. (1998) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.65.5.774 · Cited by 80
Effect of L-Dopa on the Sleep of Man
Wyatt, R. J., Chase, T. N., Scott, J., Snyder, F. R., & ENGLEMAN, K. (1970) · Nature · doi:10.1038/228999a0 · Cited by 73
Kaufer, D. (1998) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000051193 · Cited by 64
Psychological, Psychophysiological, and Biochemical Correlates of Prolonged Sleep Deprivation
KOLLAR, E. J., PASNAU, R. O., Rubín, R. T., Naitoh, P., Slater, G. G., & Kales, A. (1969) · American Journal of Psychiatry · doi:10.1176/ajp.126.4.488 · Cited by 61
Tacrine for senile dementia of Alzheimer's or Lewy body type
Wilcock, G., & Scott, M. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91933-x · Cited by 40
Longus cervicis colli "myositis" (syn: retropharyngeal tendinitis)
Pearce, J. M. S. (1996) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.61.3.324 · Cited by 40
Managing Psychosis in Patients with Parkinson's Disease
Cummings, J. L. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401011 · Cited by 39
Coexisting Tardive Dyskinesia and Parkinsonian Symptoms
Goetz, C. G. (1982) · American Journal of Psychiatry · doi:10.1176/ajp.139.11.1526 · Cited by 37
Hallucinations in Parkinson's disease: Characteristics and associated clinical features
Haeske-Dewick, H. (1995) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.930100608 · Cited by 23
Cited by
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Self-citationClinical diagnostic criteria for dementia associated with Parkinson’s disease
Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., Cummings, J., Dickson, D. W., Gauthier, S., et al. (2007) · Movement Disorders · doi:10.1002/mds.21507 · Cited by 3,027
Self-citationRivastigmine for Dementia Associated with Parkinson's Disease
Emre, M., Aarsland, D., Albanese, A., Byrne, E. J., Deuschl, G., De Deyn, P. P., Durif, F., Kulisevsky, J., van Laar, T., Lees, A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041470 · Cited by 1,223
Dementia associated with Parkinson's disease
Emre, M. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00351-x · Cited by 685
Burton, E. J. (2004) · Brain · doi:10.1093/brain/awh088 · Cited by 647
Metadata
- Authors
- Reading, P. J., Luce, A. K., & McKeith, I. G.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2001-11
- Volume
- 16
- Issue
- 6
- Pages
- 1171-1174
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2026376363
- Cited by
- 272
- References
- 38
- FWCI
- 17.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.